Get started
SINSIN PHARMACEUTICAL CO., LTD.SS

SINSIN PHARMACEUTICAL CO., LTD.

6,120KRWD
+20+0.33%
At close at May 30, 09:00 GMT
KRW
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

002800 fundamentals

Key facts

Market capitalization‪92.84 B‬KRW
Dividend yield (indicated)0.98%
Price to earnings Ratio (TTM)16.75
Basic EPS (TTM)364.11KRW
Founded1959
Employees (FY)352
CEOByung-Gi Lee
Websitesinsin.com
About

Sinsin Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. Its products include water patches, air spray patches, insect repellents, and patches for muscle pain, joint pain, neuralgia and insect bites. The company was founded on September 9, 1959 and is headquartered in Sejong, South Korea.

Ownership
‪‪15.17 M‬‬
Closely held shares
‪‪7.94 M‬‬ (52.36%)
Free Float shares
‪‪7.23 M‬‬ (47.64%)
Closely held shares
‪‪7.94 M‬‬ (52.36%)
Free Float shares
‪‪7.23 M‬‬ (47.64%)
Capital structure
Market cap
‪‪92.84 B‬‬
Debt
‪‪45.72 B‬‬
Minority interest
‪‪−314.83 M‬‬
Cash & equivalents
‪‪958.68 M‬‬
Enterprise value
‪‪137.29 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪92.84 B‬‬
Price to earning ratio (P/E)
16.75x
Price to sales ratio (P/S)
0.86x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
16.75x
Price to sales ratio (P/S)
0.86x
Valuation ratios
‪0.00‬
‪0.25‬
‪0.50‬
‪0.75‬
‪1.00‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪7.00‬
‪14.00‬
‪21.00‬
‪28.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪1.0%‬
‪3.1%‬
‪5.2%‬
‪7.3%‬
‪9.4%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪8.00 B‬‬
‪‪16.00 B‬‬
‪‪24.00 B‬‬
‪‪32.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪7.00 B‬‬
‪‪14.00 B‬‬
‪‪21.00 B‬‬
‪‪28.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪7.00 B‬‬
‪‪14.00 B‬‬
‪‪21.00 B‬‬
‪‪28.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Pharmaceutical Products
By country
Period: 2024
South Korea

Dividends

Dividend yield, history and sustainability

Dividend summary
16.48%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.98%
Last payment
60.00
Last ex-date
Dec 27, 2024
Last pay date
Apr 18, 2025
Dividend history
‪0.0%‬
‪0.3%‬
‪0.6%‬
‪0.9%‬
‪1.2%‬
2020
2021
2022
2023
2024
‪0.00‬
‪15.00‬
‪30.00‬
‪45.00‬
‪60.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−16.00 B‬‬
‪0.00‬
‪‪16.00 B‬‬
‪‪32.00 B‬‬
‪‪48.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪20.00 B‬‬
‪‪40.00 B‬‬
‪‪60.00 B‬‬
‪‪80.00 B‬‬
Assets
Liabilities